Ipsen receives new palovarotene PDUFA date; Acer halts development of ex-Sanofi drug
The FDA will be giving Ipsen another shot at approval for one of its candidates.
Ipsen announced that the FDA has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
